Astute traders could not pass up easy money. They
Post# of 36537
(Total Views: 170)
Posted On: 02/11/2019 1:22:08 PM
Astute traders could not pass up easy money. They took it, sold, came back for the NGIO spin-off and sold again. The month long wait to go ex-div gave them a chance to sell and get back in, waiting for the next catalyst.
Anyone truly paying attention has focused on the MSO business plan. This is in its infancy. If you like it, you’ll stay. If not, you’ll sell. Mgmt has earned sufficient cred to give them a chance to solve their $682K dilemma. They’ll take care of it, IMO. If we get a pop over $2, sell and take a little profit. Otherwise, pay attention and employ discipline with the rest of the shares. Personally, I expect news leading up to the spin off. Mgmt knows how to create and maintain interest. As someone else said, a PR every day, without substance, is pump n dump.
Anyone truly paying attention has focused on the MSO business plan. This is in its infancy. If you like it, you’ll stay. If not, you’ll sell. Mgmt has earned sufficient cred to give them a chance to solve their $682K dilemma. They’ll take care of it, IMO. If we get a pop over $2, sell and take a little profit. Otherwise, pay attention and employ discipline with the rest of the shares. Personally, I expect news leading up to the spin off. Mgmt knows how to create and maintain interest. As someone else said, a PR every day, without substance, is pump n dump.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼